Eye Drops for Ocular Shingles (Herpes Zoster)
Topical antiviral eye drops alone have not been shown to be helpful in treating varicella zoster virus (VZV) conjunctivitis and should not be relied upon as primary therapy 1.
Primary Treatment Approach
The cornerstone of treatment for ocular shingles is oral antiviral therapy, not topical antivirals. According to the 2024 American Academy of Ophthalmology guidelines, the recommended oral regimens are 1:
- Acyclovir 800 mg five times daily for 7 days, OR
- Valacyclovir 1000 mg every 8 hours for 7 days, OR
- Famciclovir 500 mg three times daily for 7 days
When Topical Antivirals May Be Considered
While topical antivirals are not effective as monotherapy, they may be used as additive treatment in unresponsive patients 1. The available topical antiviral options include:
- Ganciclovir 0.15% gel (3-5 times daily)
- Trifluridine 1% solution (5-8 times daily)
However, these are primarily indicated for HSV keratitis, not VZV conjunctivitis, and should only be added if there is concurrent corneal involvement that is not responding to oral therapy alone.
Topical Antibiotics Are More Important
The primary topical therapy for VZV conjunctivitis is actually topical antibiotics, not antivirals 1. This is because the eyelid and conjunctival vesicles undergo necrosis before healing, creating risk for secondary bacterial infection that can lead to severe conjunctival scarring and even cicatricial ectropion.
Critical Caveats
Prolonged or Chronic Disease
- Patients with persistent or recalcitrant disease may require prolonged oral antiviral treatment with dose adjustments based on clinical response
- Chronic sequelae may necessitate long-term prophylaxis 1
Immunocompromised Patients
- Require more aggressive treatment
- May need higher doses or longer duration of oral antivirals 1
Renal Function
- Exercise caution with systemic antivirals in patients with impaired renal clearance and adjust dosing accordingly 1
Complications Requiring Different Management
VZV can cause multiple ocular complications including pseudodendrites, keratitis, corneal scarring, iritis/uveitis, sectoral iris atrophy, and secondary glaucoma 1. These may require additional therapies beyond antivirals.
Late Sequelae
Watch for dry eye and corneal anesthesia with neurotrophic keratitis as late complications 1.
Bottom Line
Do not prescribe topical antiviral eye drops as primary treatment for shingles affecting the eye—prescribe oral antivirals instead. Use topical antibiotics to prevent secondary bacterial infection of the vesicular lesions. Reserve topical antivirals only as adjunctive therapy in cases with corneal involvement that fail to respond to oral therapy alone.